Table 1 Comparison between the convertors and non-convertors at baseline of the study as regard clinical, radiological, and neurophysiological data
Clinical data | Group 1a (convertors) (n = 8) | Group 1b (non-convertors) (n = 35) | p value |
|---|---|---|---|
Age (years) | 26.9 ± 4.4 | 30.3 ± 4.5 | 0.06 |
Sex | |||
Male | 0 (0%) | 9 (26%) | 0.2 |
Female | 8 (100%) | 26 (74%) | |
Clinical presentation (%) | |||
Optic neuritis | 6 (75%) | 19 (54%) | |
Spinal cord disorder | 2 (25%) | 16 (46%) | 0.05 |
EDSS | 2.25 ± 1.07 | 1.9 ± 0.91 | 0.4 |
Patients with delayedP100 latency (%) | 2 (25%) | 20(57%) | 0.2 |
MRI T2 lesion number | 7.4 ± 3.5 | 2.3 ± 2.2 | < 0.001* |
Gd-enhancing lesions | |||
No enhancement | 5 (62.5%) | 22 (62.9%) | 0.6 |
Contrast enhancement | 3 (37.5%) | 13 (37.1%) | |